Related by context. All words. (Click for frequent words.) 82 Main Outcome Measure 70 Outcome Measures 70 Depressive Symptoms 69 Treatment Outcome 68 Clinical Outcome 68 ANCOVA 68 Pain Intensity 67 Assessment Questionnaire 67 Brief Psychiatric 66 Correlates 66 Histologic 66 EQ 5D 66 Comorbidities 65 subscores 65 Virologic Response 65 Lesion 65 Prognostic 65 Severity Index 65 Orthostatic Hypotension 65 Mortality Risk 65 interobserver 65 Functional Outcomes 65 Kidney Function 65 Sleep Disturbance 65 Prognostic Value 65 Comorbidity 65 Meta Analysis 65 Risk Stratification 65 Histological 65 Diagnostic Criteria 65 Univariate 65 Statistically Significant 65 Subscale 65 mean ± SEM 65 Alzheimer Disease Assessment 64 Postoperative 64 Respiratory Symptoms 64 Anxiety Depression 64 Coronary Artery Bypass Surgery 64 Functional Assessment 64 Differential Diagnosis 64 Levels Linked 64 Score TOS 64 Severity MSCS score 64 Physiologic 64 subscale scores 64 SF #v# 64 Ischemic Stroke 64 Homeostasis 64 Patients Receiving 64 Anthropometric 64 Histopathologic 64 Breast Tissue 64 Correlated 64 Cognitive Dysfunction 64 fasting plasma 64 Fracture Risk 64 Determinants 64 Cognitive Function 64 Montgomery Asberg Depression 64 Endothelial Function 64 Score IPSS 64 Sexual Satisfaction 64 Echocardiographic 64 Mammographic 64 Symptom Checklist 64 Assessment Scale 64 Left Ventricular 64 Ocular Surface Disease 64 Breast Carcinoma 64 Pathologic 64 Prognostic Factors 64 Predictors 63 Global Impression CGI 63 Chronic Illness Therapy 63 bivariate 63 Visual Analogue Scale VAS 63 Univariate analysis 63 Dyspnea 63 Subtypes 63 Postprandial 63 Lower Limb 63 posttreatment 63 Secondary Endpoints 63 Clinical Relevance 63 Predictive Value 63 Hemodialysis Patients 63 pain subscale 63 Cognitive Impairment 63 Health Assessment Questionnaire 63 Rating Scale MADRS 63 Symptom Scale 63 Angiographic 63 Systolic 63 Preoperative 63 Improves Outcomes 63 Montgomery Åsberg Depression 63 Brief Pain 63 logistic regression analyzes 63 Showed Significant 63 Rating Scale UPDRS 63 Prostatic 63 Patellofemoral 63 Myocardial Perfusion 63 Predict Response 63 ‰ ¥ 63 Laryngeal Cancer 63 Progenitor Cells 63 Modulates 63 Hippocampal 63 International Prostate Symptom 63 Specificity 63 Visual Analog Scale 63 covariate 63 Score DAS 63 Distress Scale 62 Thrombotic 62 Predict Prostate Cancer 62 Pharmacologic 62 multiple logistic regression 62 Scale Revised 62 Pearson correlation coefficient 62 Localized Prostate Cancer 62 Wechsler Adult 62 HRQL 62 Non Responders 62 Adiposity 62 Sonographic 62 Randomized Controlled Trials 62 Quantification 62 Long Term Outcomes 62 Relapsing Remitting Multiple Sclerosis 62 Critically Ill Patients 62 Epithelial Cell 62 Acute Physiology 62 Modifiable 62 Endocrine Therapy 62 Invasive Breast Cancer 62 Cystatin C 62 logistic regression analysis 62 intraclass correlation coefficients 62 Treating Chronic 62 Symptom Severity 62 Stress Induced 62 -#.# ± [002] 62 Vertebral Fractures 62 Thromboembolic 62 Significant Reduction 62 Platelet Aggregation 62 Cronbach alpha 62 multivariable analysis 62 Insulin Sensitivity 62 Suicidal Ideation 62 Coronary Artery Calcium 62 Impairs 62 Tumor Response 62 subscore 62 Lipid Levels 62 Scale PANSS 62 Beta Blockers 62 EORTC QLQ C# 62 Mean Symptom Complex 62 Peripheral Arterial 62 Node Negative 61 Coronary Arteries 61 Carotid Stenting 61 HOMA IR 61 morphologic characteristics 61 Suboptimal 61 Lowers Risk 61 interrater reliability 61 Oropharyngeal 61 Ischaemic 61 Glycemic Control 61 Intra Arterial 61 confidence intervals CIs 61 subscales 61 Prophylactic Treatment 61 multivariate analyzes 61 State Examination MMSE 61 Intervention Trial 61 Self Efficacy 61 Renal Function 61 Prostate Cancer Recurrence 61 logistic regression model 61 Rating Scale BPRS 61 Bloodstream Infections 61 Severity Index PASI 61 Metastatic Renal Cell Carcinoma 61 Malignancy 61 Somnolence 61 Cognitive Ability 61 Who Underwent 61 Predict Risk 61 Cardiovascular Outcomes 61 Genes Linked 61 Logistic Regression 61 Index CDAI 61 Rheumatoid Arthritis Patients 61 WOMAC pain 61 Prospective Cohort Study 61 Outcomes Study 61 Depression Anxiety 61 Infarction 61 Symptom 61 Pharmacodynamic 61 odds ratios ORs 61 Polymorphism 61 Hormonal Therapy 61 Lung Cancer Trial 61 Secretory 61 Visual Analog 61 Demonstrated Significant 61 Help Predict 61 Correlation Between 61 Insufficiency 61 Abdominal Fat 61 Lymph Nodes 61 semiquantitative 61 Symptom severity 61 NIH CPSI 61 Heterogeneity 61 Secondary endpoints include 61 Abnormality 61 Randomized Trials 61 Neurocognitive 61 Secondary endpoints included 61 % Confidence Interval 61 Abdominal Pain 61 Fecal Incontinence 61 Pulmonary Artery 61 Statin Therapy 61 baseline FEV 61 Patient Outcomes 61 ADCS CGIC 61 Neoplasms 61 Excretion 61 Stratification 61 Lung Injury 61 logistic regression 61 Appears Safe 61 Bioavailability 61 Left Atrial 61 aspartate aminotransferase AST 61 Acceptability 61 Infarct 61 Etiology 61 Supplemental Figure 61 Sensitivity Analysis 60 DAS# scores 60 univariate 60 Immune Responses 60 Prefrontal 60 Test Detects 60 Evaluable 60 ANOVA 60 Relapsing Multiple Sclerosis 60 Patency 60 clinicopathological features 60 univariate analysis 60 Quantifiable 60 BMI z 60 Obese Patients 60 intact parathyroid hormone 60 Iron Overload 60 Study Shows Significant 60 Multivariate 60 Septic Shock 60 Preterm Infants 60 anthropometric measures 60 Physical Function 60 Bone Mineral Density 60 Signaling Pathways 60 Sleep Disturbances 60 D Dimer 60 Axillary 60 CFQ R 60 Radiation Dose 60 International Prognostic Scoring 60 Stable Angina 60 Follicular Lymphoma 60 Tumor Cell 60 Helps Relieve 60 Inflammatory Pain 60 Radiation Induced 60 Reduced Risk 60 F FDG PET 60 Genetic Variants 60 univariate analyzes 60 Primary endpoints 60 Ischemic 60 preoperative PSA 60 Subclinical 60 Radical Prostatectomy 60 Dose Response 60 Lower Extremity 60 Cervical Spine 60 Pediatric Patients 60 Elderly Patients 60 Cytogenetic 60 HADS 60 Conformational 60 Patients Undergoing 60 Hemoglobin A1c 60 Adverse Event 60 Bone Metastases 60 premorbid 60 Radiographic 60 Survival Rate 60 Circadian Clock 60 Amniotic Fluid 60 Crohn Disease Activity 60 HRCT 60 Variability 60 estimated glomerular filtration 60 Medication Adherence 60 Discrepancy 60 Uterine 60 affective psychosis 60 Hemodynamic 60 Negative Syndrome 60 Genetic Marker 60 Neuropsychiatric Inventory 60 Prostate Cancer Risk 60 Cognitive Problems 60 Adjuvant Therapy 60 Hip Fracture 60 Randomized Controlled 60 Double Blind Randomized 60 PANSS Positive 60 Could Predict 60 Sexual Desire 60 sociodemographic characteristics 60 Genes Associated 60 Mitotic 60 Data Suggest 60 Viral Load 60 Knee Osteoarthritis 60 Cystic Fibrosis Questionnaire Revised 60 Intraocular Pressure 60 Immunologic 60 Gender Differences 60 multivariable analyzes 60 Effective Treatments 60 Pregnancy Outcomes 60 plasma cortisol 60 generalized estimating 60 Myocardial 60 Hematocrit 60 Vertebral 60 Malignant Glioma 60 Venous Thromboembolism 60 clinicopathological 60 Gene Variants 60 CORE OM 60 Morbidity Mortality 60 Forced Vital 60 depressive symptomatology 60 Symptom Score 60 Thrombolysis 60 Shows Promise Against 60 Evoked 60 Gene Linked 60 State Exam MMSE 60 Cardiac Resynchronization 60 Immunosuppression 60 Socioeconomic Status 60 IPSS 60 Endometrial Cancer 59 Neuroprotective Effects 59 Restless Legs 59 RT qPCR 59 Atopic Dermatitis 59 Intracranial 59 Neuropsychological 59 Nonalcoholic Fatty Liver Disease 59 Antidepressants Linked 59 Combination Treatment 59 Carotid Endarterectomy 59 Pulsatile 59 Renal Insufficiency 59 Can Predict 59 Induction Therapy 59 Cognitive Functioning 59 Often Misdiagnosed 59 Hospitalized Patients 59 echocardiographic parameters 59 Proteinuria 59 Hamilton Rating Scale 59 Significantly Improved 59 Adenomas 59 IBDQ 59 Alkaline Phosphatase 59 Coronary Calcium 59 Pharmacodynamics 59 Solid Tumors 59 Glomerular Filtration Rate 59 State Trait Anxiety 59 PCWP 59 Recurrent Breast Cancer 59 intraclass correlation coefficient 59 Myocardial Ischemia 59 pharmacodynamic parameters 59 Brain Metastases 59 Study Demonstrates 59 Beta Amyloid 59 immunostaining 59 Help Detect 59 Depressive Symptomatology 59 Lung Cancer Survival 59 Rating Scale 59 Neuropsychiatric Inventory NPI 59 CIBIC + 59 TIMP 1 59 PANSS 59 Inflammatory Markers 59 Radiofrequency Ablation 59 intraobserver 59 Sentinel Lymph Node Biopsy 59 Fibromyalgia Impact Questionnaire 59 UPDRS 59 Psoriasis Area 59 inhibin B 59 multivariable adjusted 59 Skin Lesions 59 Diastolic Heart Failure 59 Skeletal Muscle 59 Proves Effective 59 Coronary Artery Bypass Graft 59 Clinical Significance 59 Reproducibility 59 ± SEM 59 Pooled Analysis 59 Preoperatively 59 Retreatment 59 Pharmacokinetic 59 Combo Therapy 59 Long Term Efficacy 59 multivariate Cox 59 bivariate analysis 59 Imaging Techniques 59 ADAS cog 59 haematologic 59 Placebo Controlled Trial 59 Inhaled Nitric Oxide 59 Dissociation 59 Renal Cell Carcinoma 59 SGRQ 59 Adjuvant Chemotherapy 59 Psychiatric Disorders 59 Tumor Progression 59 Inflammatory Response 59 Acute Pancreatitis 59 Controlled Trial 59 metabolite concentrations 59 Determinant 59 Cognitive Decline 59 TLUS 59 Placebo Controlled Study 59 Novel Inhibitor 59 Clinical Evaluation 59 Strongly Linked 59 Morphological 59 Prolongs Survival 59 exploratory endpoints 59 Gene Mutation 59 Stent Placement 59 Scale Cognitive Subscale 59 Hypertensive Patients 59 DAS# CRP 59 Hormone Receptor Positive 59 cerebral oxygenation 59 Mental Component 59 Helps Identify 59 esophageal carcinoma 59 #q# deletion syndrome 59 Genes Predict 59 Randomized Study 59 Viral Suppression 59 HRQOL 59 Adenoma 59 correlation coefficients 59 Antidepressant Treatment 59 Aggressive Prostate Cancer 59 Shows Promising 59 Helps Predict 59 Prognostic Significance 59 Treated Patients 59 Complicated Grief 59 aminotransferase 59 HRQoL 59 Predisposition 59 MR Angiography 59 Breast Density 59 Mouse Model 59 Prevent Stroke 59 pT2 59 Index FSFI 59 ST Segment Elevation 59 waist circumference WC 59 Prostate Biopsy 59 Reduces Pain 59 syndromal 59 Panic Disorder 59 Abnormal Involuntary Movement 59 Reevaluation 59 Stenosis 59 Improve Survival 59 Randomized Evaluation 59 Systolic Blood Pressure 59 Cerebellar 59 Improves Survival 59 MSLT 59 STRIDE PD 59 YMRS 59 Multicenter Trial 59 Study Shows Benefits 59 Endothelium 59 Liver Failure 59 Genetic Markers 59 Microalbuminuria 59 Blood Glucose 59 Severity Scale 59 Dilatation 59 Cholinesterase Inhibitors 59 MDRD 59 Psychiatric Illness 59 tertiles 59 Various Types 59 Radiation Exposure 59 Sustained Virologic Response 59 Cockcroft Gault 59 Hypercholesterolemia 59 Heart Failure Patients 59 Female Sexual Function 59 Macroscopic 59 Hemolysis 59 Androgen 59 Urinary 59 Improve Outcomes 59 Prognostic significance 59 Kaplan Meier estimates 59 Catheter Ablation 59 Chronic Renal Failure 59 Coronary Angiography 59 Renal Cancer 59 Cardiogenic Shock 59 Usefulness 59 Partial Response 59 Thrombus 59 Controlled Study 59 Hormone Levels 59 Incontinence Impact Questionnaire 58 Surgical Procedures 58 Adjuvant Treatment 58 Sex Hormones 58 Cancer Recurrence 58 Significantly Reduces 58 prespecified secondary 58 Diabetic Foot Ulcer 58 Adipose Tissue 58 Secretion 58 Stent Restenosis 58 spirometric 58 Ejection Fraction 58 Pharmacologic Treatment 58 Lowers Blood Pressure 58 FOR AN OPEN 58 Sleep Duration 58 Embolism 58 Left Ventricular Ejection Fraction 58 Study Casts Doubt 58 Affective 58 Substantially Reduce 58 Protein Linked 58 Diagnostic Tests 58 Insulin Therapy 58 Autologous Stem Cell Transplantation 58 Brain Atrophy 58 Hypertrophy 58 Cortical 58 Erectile Function IIEF 58 Long Term Survival 58 Reveals Significant 58 Cell Adhesion 58 Prospective Randomized 58 Symptom Improvement 58 Peritoneal 58 Therapy Improves 58 urodynamic parameters 58 cTnI 58 Attenuation 58 Sirolimus Eluting Stent 58 Randomized Clinical Trial 58 Eye Diseases 58 Generalized Anxiety Disorder 58 albumin excretion rate 58 RECIST Response Evaluation Criteria 58 Phenotypic 58 serum lactate 58 Lung Function 58 Scale EDSS score 58 Sustained Efficacy 58 Malignancies 58 specific antigen PSA 58 Reduces Risk 58 Prostate Specific Antigen 58 HAQ DI 58 Depression Inventory 58 Chromosomal 58 Seattle Angina Questionnaire 58 Genotypes 58 postintervention 58 Non Invasive Treatment 58 Neoadjuvant Chemotherapy 58 Partial Nephrectomy 58 Geriatric Depression 58 Antibiotic Therapy 58 Demonstrates Positive 58 Carotid 58 Screening Mammography 58 serum estradiol 58 AST ALT 58 Increased Mortality 58 Study Evaluating 58 Iron Deficiency 58 Ureteral 58 Breast Cancer Recurrence 58 Aortic Valve Replacement 58 Could Prevent 58 Contrast Agents 58 Adverse Effects 58 leukocyte counts 58 Exposure Linked 58 meta regression 58 coronary stenosis 58 Brain Function 58 Total Knee Arthroplasty 58 Renal Disease 58 Supplementary Table 58 Urine Test 58 salivary cortisol 58 Hamilton Anxiety Scale 58 Beta Blocker 58 Underlie 58 Potentially Fatal 58 Subtype 58 Plus Ribavirin 58 Castration Resistant Prostate Cancer 58 carotid artery intima media 58 Descriptive statistics 58 Evaluative 58 See CLINICAL PHARMACOLOGY 58 ADCS ADL 58 Systematic Review 58 lymphovascular invasion 58 Therapy Shows Promise 58 HDRS 58 P = .# 58 Posttraumatic Stress 58 triiodothyronine 58 Hyperlipidemia 58 Squamous Cell Carcinoma 58 Subgroup Analysis 58 Comorbid 58 Sociodemographic 58 Immunohistochemical 58 posttest 58 Sensorimotor 58 multivariate logistic regression 58 PLMs 58 Significantly Reduced 58 Repeatability 58 Fatty Liver 58 Sexual Function 58 Quantitation 58 Immunomodulatory 58 hematological parameters 58 Visual Analogue Scale 58 Significantly Improves 58 Claudication 58 Suicidality 58 ECOG PS 58 glomerular filtration rate 58 Prognostic Index 58 hemodynamic parameters 58 Clinician Administered PTSD 58 Regression Analysis 58 Reperfusion Injury 58 Histopathological 58 CIBIC plus 58 Infected Patients 58 Exacerbation 58 Newly Diagnosed Multiple Myeloma 58 Secondary Hyperparathyroidism 58 erythrocyte sedimentation rate 58 Study Sheds Light 58 Albuminuria 58 Carotid Artery Stenting 58 clinico pathological 58 Antecedents 58 untreated psychosis 58 Radiation Doses 58 Angiogenic 58 Endometrial 58 histological subtype 58 vasomotor 58 RENAL 58 Valvular 58 Erectile Function 58 p = .# [002] 58 Respiratory Distress 58 Schizophrenia Treatment 58 multivariable Cox 58 abdominal adiposity 58 WAIS III 58 Lung Tumor 58 Index WOMAC 58 Vitamin D Supplementation 58 leiomyomas 58 Gastric Cancer 58 WOMAC scores 58 cognitive affective 58 Molecular Mechanism 58 Insulin Glargine 58 inversely associated 58 Left Ventricular Hypertrophy 58 FACIT Fatigue 58 Predict Breast Cancer 58 Calorimetry 58 IIEF 58 Induces 58 Anti Tumor Activity 58 posttransplant 58 Quality Indicators 58 Macrophage 58 Multivariate analysis 58 Breast Cancers 58 Genetic Variation 58 Randomized Clinical Trials 58 etiologic 58 interquartile range IQR 58 Intracellular 58 Hypertrophic 58 CT Angiography 58 Cardiac Function 58 Patients Treated 58 Opioid Use 58 Protein Synthesis 58 Ethnic Differences 58 ultrasonographic 58 Overactive Bladder 58 Demonstrate Significant 58 Cardiovascular Events 58 Calcium Intake 58 Postoperative Ileus 58 Elastography 58 glycosylated hemoglobin HbA1c 58 Muscle Wasting 58 Intraperitoneal 58 Ultrasonography 58 Unified Parkinson Disease 58 Genetic Defect 58 Demonstrates Statistically Significant 58 left ventricular LV 58 Brain Scans 58 Dementia Risk 58 Correlation 58 Treating Depression 58 Arrhythmogenic 58 Intracranial Aneurysms 58 Renal Artery 58 Disease Progression 58 Calorie Diet 58 Protein Structure 58 Resistant Hypertension 58 Profile SEP 57 Premature Infants 57 lactate dehydrogenase LDH 57 Cholesterol Levels 57 Meta Analyses 57 WOMAC 57 dimensional echocardiography 57 TRUS 57 MADRS score 57 alanine aminotransferase 57 surgically resected 57 Structure Function 57 Inhibitory 57 Cause Mortality 57 Cardiovascular Disease Risk 57 Wound Closure 57 Psychodynamic Psychotherapy 57 comorbid anxiety 57 IRLS 57 Hip Fracture Risk 57 Chemotherapeutic Agents 57 Neuroticism 57 Subgroup analysis 57 Chronic Insomnia 57 Psychological Effects 57 Kidney Transplants 57 Physical Component 57 Hormone Replacement 57 Reperfusion 57 Multiple Myeloma Patients 57 dyspnoea 57 Hormone Refractory Prostate Cancer 57 Cardiorespiratory 57 bivariate analyzes 57 Virus Infection 57 Slow Progression 57 Cerebrospinal Fluid 57 Oral Fingolimod 57 C Reactive Protein 57 3rd edn 57 Contrast Enhanced 57 Watchful Waiting 57 transcranial Doppler ultrasound 57 affective disorders 57 Persistent Sleep 57 Mitochondrial Dysfunction 57 Thymic 57 Intracerebral Hemorrhage 57 Digit Symbol Substitution 57 Acute Coronary Syndromes 57 Gene Mutations 57 SGPT 57 Expanded Disability Status 57 covariance ANCOVA 57 SGOT 57 Hepatitis C Genotype 57 Being Studied 57 hemoglobin Hb 57 Pelvic Organ Prolapse 57 Injury Severity Score 57 Cervical Dysplasia 57 arterial oxygen saturation 57 Obesity Linked 57 NYHA functional class 57 Child Behavior Checklist 57 Blepharospasm 57 FDG uptake 57 Hemoglobin Levels 57 Proliferative 57 Prostatectomy 57 Depression Scale HADS 57 renal cysts 57 Study Compares 57 Catheter Associated 57 Improves Quality 57 Myocardial Infarction TIMI 57 Treatment Reduces 57 Sustained Reduction 57 bronchoalveolar lavage BAL 57 BEXXAR Therapeutic Regimen 57 Pharmacokinetic Study 57 Androgen Deprivation 57 psychometric properties 57 Inhaled Corticosteroids 57 APACHE II 57 Contralateral 57 SCr 57 Sleep Patterns 57 Desvenlafaxine Succinate 57 UPDRS Part III 57 Cognitively Impaired 57 Arterial Disease 57 Mortality Rate 57 hyperintensity 57 Major Adverse Cardiac 57 multivariable logistic regression 57 serum IGF 57 SELENA SLEDAI 57 serum leptin 57 elevated creatinine 57 Recurrence 57 elevated transaminases 57 ACER paper 57 Muscle Cells 57 Lipoprotein 57 covariance 57 Short Stature 57 Randomized Controlled Trial 57 Metastases 57 Tumor Suppressor Gene 57 Psychiatric Diagnosis 57 hemodilution 57 Diagnosis Treatment 57 electrophysiologic 57 Normative 57 Percutaneous Tibial Nerve Stimulation 57 Postoperative Pain 57 Solubility 57 Insulin sensitivity 57 Acute Kidney 57 Diabetic Kidney Disease 57 Deleterious 57 Asymptomatic 57 variance ANOVA 57 Skin sterol 57 undetectable HBV DNA 57 Finger Length 57 myocardial viability 57 Potent Anti 57 Node Positive 57 Prolongs Life 57 Antitumor 57 Estrogen Receptor 57 Demonstrates Efficacy 57 Psychodynamic 57 Erythropoietic 57 recurrent venous thromboembolism 57 Spinal Fluid 57 Haplotype 57 Impedance 57 ERalpha 57 Secondary efficacy endpoints 57 Preclinical Models 57 Antibiotic Treatment 57 Quartile 57 Potent Inhibitor 57 bronchoalveolar lavage 57 carotid intima media 57 comorbidity 57 Cardiorespiratory fitness 57 histopathological 57 lymphocyte count 57 ALS Functional 57 linear regression analyzes 57 Intubation 57 Electrical Stimulation 57 Kaplan Meier curves 57 MADRS 57 Magnetic Stimulation 57 QoL 57 Testicular 57 ADAS Cog 57 Positively Impacts 57 rCBF 57 Depression Scale 57 Childhood Trauma 57 Inhibits 57 Subjective 57 convergent validity 57 Intraoperative 57 Numeric Rating Scale 57 Significant Improvements 57 Transcriptional 57 Pain Rating Scale 57 adrenocortical 57 periprocedural 57 FDG-PET/CT 57 Spinal Manipulation 57 Cardiotoxicity 57 Commonly Used 57 Study Analyzes 57 trough FEV1 57 Erectile 57 Fewer Side Effects 57 erection hardness 57 Highly Selective 57 sociodemographic variables 57 Benign Prostatic Hyperplasia 57 Metastatic Prostate Cancer 57 Clinical Efficacy 57 Novel Approach 57 Non Inferiority 57 Premature Ejaculation 57 MMSE score 57 Preterm Labor 57 Oral Cavity 57 Dosing Regimen 57 Hypotension 57 interobserver agreement 57 Efficacy Endpoints 57 Inj 57 NHANES III 57 Clinical Decision Making 57 LV ejection fraction 57 Uric Acid 57 fasting insulin 57 Salivary 57 Scale cognitive subscale 57 Gene Variant 57 Randomized Placebo Controlled Trial 57 Response Evaluation Criteria 57 Patients Treated With 57 Quotient TM 57 interrater 57 Brain Shrinkage 57 #:#-# [029] 57 Pearson correlation coefficients 57 total cholesterol triglycerides 57 Synaptic Plasticity 57 Effectively Treats 57 antibody titer 57 Minimally Invasive Treatment 57 Immunohistochemistry